Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer | NEJM
Original Article from The New England Journal of Medicine — Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
Original Article from The New England Journal of Medicine — Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
50% of men treated for prostate cancer will experience recurrence. Especially for men with a family history of prostate cancer, who’ve been diagnosed with prostate…
Stacy Loeb: Join the Prostate Cancer Summit led by Geo Espinosa / cancer, cancer care, Geo Espinosa, nutrition, NYU Langone, OncoDaily, Oncology, prostate
50% of men treated for prostate cancer will experience recurrence. Especially for men with a family history of prostate cancer, who’ve been diagnosed with prostate…
Prostate cancer is often referred to as a “couple’s disease.” Prostate cancer and its treatments can have a significant negative impact on sexual quality
Health misinformation is prolific online, particularly on social media platforms like TikTok, YouTube and Instagram. Search for any health term and you’re bound to find…
Background Black men consistently have higher rates of prostate cancer (PCA)- related mortality. Advances in PCA treatment, screening, and hereditary cancer assessment center around germline…
This cross-sectional study examines the readability and quality differences in cancer information found on free and paywalled versions of a chatbot.
Exposure to occupational radiation can lower the male sex ratio. However, specific radiation exposure to the testes has not been evaluated.This study aimed to examine…
Please join us for a PCF Virtual Patient & Caregiver Summit on Localized Prostate Cancer. Learn about latest developments in localized prostate cancer treatment, managing…
This cross-sectional study examines the association of life expectancy and prostate cancer screening practices among older males using data from a national survey.